Intensive five‐drug combination chemotherapy for adult acute non‐lymphocytic leukemia

Bruce A Peterson, Clara D. Bloomfield, George J. Bosl, Gerald Gibbs, Margo Malloy

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

Twenty‐two newly diagnosed adults with acute non‐lymphocytic leukemia (ANLL) and 18 who had relapsed from a prior complete remission (CR) obtained with intensive chemotherapy were treated with a combination of Adriamycin, cytosine arabinoside, 6‐thioguanine, prednisone, and vincristine. Eighteen (82%) of the patients undergoing initial induction therapy, including 4 of 6 patients over 60 years of age, achieved CR. Twelve patients (67%) undergoing reinduction therapy also achieved CR. Twenty‐three (77%) of the 30 CRs were obtained with only one course of chemotherapy. The median time to CR for those undergoing initial treatment was 32 days, and the median duration of CR is 10+ months. The median survival for all 22 newly diagnosed patients is 15 + months. This intensive five‐drug regimen is highly effective for the remission induction of both newly diagnosed and previously treated patients with ANLL producing a high percentage of CRs with only one course of therapy.

Original languageEnglish (US)
Pages (from-to)663-668
Number of pages6
JournalCancer
Volume46
Issue number4
DOIs
StatePublished - Aug 15 1980

Fingerprint Dive into the research topics of 'Intensive five‐drug combination chemotherapy for adult acute non‐lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this